首页> 外文期刊>Trials >Classic yin and yang tonic formula for osteopenia: study protocol for a randomized controlled trial
【24h】

Classic yin and yang tonic formula for osteopenia: study protocol for a randomized controlled trial

机译:骨质减少的经典阴阳补品配方:一项随机对照试验的研究方案

获取原文
           

摘要

Background Osteoporosis is a growing worldwide problem, with the greatest burden resulting from fractures. Nevertheless, the majority of fractures in adults occur in those with "osteopenia" (bone mineral density (BMD) only moderately lower than young normal individuals). Since long-term drug therapy is an expensive option with uncertain consequences and side effects, natural herbal therapy offers an attractive alternative. The purpose of this study is to evaluate the effect on BMD and safety of the Classic Yin and Yang Tonic Formula for treatment of osteopenia and to investigate the mechanism by which this efficacy is achieved. Methods/design We propose a multicenter double-blind randomized placebo-controlled trial to evaluate the efficacy and safety of the Classic Yin and Yang Tonic Formula for the treatment of osteopenia. Participants aged 55 to 75 with low bone mineral density (T-score between -1 and -2.5) and kidney deficiency in TCM will be included and randomly allocated into two groups: treatment group and control group. Participants in the treatment group will be treated with Classic Yin and Yang Tonic Granule, while the controlled group will receive placebo. Primary outcome measure will be BMD of the lumbar spine and proximal femur using dual-energy X-ray absorptiometry. Secondary outcomes will include pain intensity measured with visual analogue scales, quality of life, serum markers of bone metabolism, indices of Neuro-endocrino-immune network and safety. Discussion If the Classic Yin and Yang Tonic Formula can increase bone mass without adverse effects, it may be a novel strategy for the treatment of osteoporosis. Furthermore, the mechanism of the Chinese medical formula for osteoporosis will be partially elucidated. Trial registration This study is registered at ClinicalTrials.gov, NCT01271647 .
机译:背景技术骨质疏松症是一个日益严重的全球性问题,骨折带来的负担最大。然而,成年人的大多数骨折发生在“骨质减少”患者中(骨矿物质密度(BMD)仅比中青年正常人低一些)。由于长期药物治疗是一种昂贵的选择,具有不确定的后果和副作用,因此天然草药治疗提供了一种有吸引力的选择。这项研究的目的是评估经典的阴阳补品配方对骨质疏松症的骨密度和安全性的影响,并研究达到此功效的机理。方法/设计我们提出了一项多中心双盲随机安慰剂对照试验,以评估经典阴阳补品配方治疗骨质疏松的疗效和安全性。年龄在55至75岁之间且骨矿物质密度低(T评分在-1和-2.5之间)且中医肾虚的参与者将被纳入研究并随机分为两组:治疗组和对照组。治疗组的参与者将接受经典阴阳补品颗粒的治疗,而对照组则接受安慰剂。主要结局指标为采用双能X线吸收法测定腰椎和股骨近端的BMD。次要结果包括通过视觉模拟量表测量的疼痛强度,生活质量,骨代谢的血清标志物,神经内分泌免疫网络的指数和安全性。讨论如果经典的阴阳补品配方可以增加骨质而无不良影响,则可能是治疗骨质疏松症的新策略。此外,将部分阐明中医配方用于骨质疏松症的机制。试验注册本研究已在ClinicalTrials.gov,NCT01271647上注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号